Skip to content

A Retrospective Analysis of needle-knife combined with fire needle in the treatment of keloids

A Retrospective Analysis of needle-knife combined with fire needle in the treatment of keloids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001876
Enrollment
Unknown
Registered
2025-10-11
Start date
2024-12-04
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloids

Interventions

Observation group:needle-knife combined with fire needle

Sponsors

Shanghai Ninth Peoples Hospital Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)According to the diagnostic criteria in the "Recommendations for the Diagnosis and Treatment of Keloids":1) The mass protruded on the skin surface hard smooth and shiny with irregular boundaries and there was no sign of retraction within one year; 2) The lesions extended beyond the boundary of the original lesion and infiltrated into the surrounding normal tissues like crab feet; 3) Persistent growth accompanied by symptoms such as redness pain and itching without self-healing and dampness unable to subside; 4) Recurrence is more likely to occur after simple surgical resection and the recurrence area is beyond the original scar area; 5) The pathological examination showed that the keloid tissue had a large amount of collagen and matrix deposition a large number of fibroblasts and mitotic figures. (2) The patients were between 18 and 70 years old (including 18 and 70 years old) male or female and the disease duration was more than or equal to one year1 year. (3) Single or multiple keloids with area less than or equal to 9.0 cm, 2 0.5-5.0 mm elevated and protruding from the skin surface located in the lower jaw chest and abdomen shoulder and back limbs and perineum. Only if the above 3 items are met can be included.

Exclusion criteria

Exclusion criteria: (1) combined with serious primary diseases of the heart brain liver kidney blood system and basic diseases such as tumors; (2) pregnant or lactating women; (3) patients who received hormone injection or other treatment within 3 months before or during the treatment; (4) missing or incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Vancouver Scar Scale;

Secondary

MeasureTime frame
Visual Analogue Score;

Countries

China

Contacts

Public ContactWAN Yi

Shanghai Ninth Peoples Hospital Shanghai Jiao Tong University School of Medicine

wanyi1027@126.com13917701346

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026